Protein-Based Biosensors and Biomaterials for Diagnostic Application and Drug Discovery
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmaceutical Technology".
Deadline for manuscript submissions: closed (25 April 2024) | Viewed by 281
Special Issue Editors
Interests: biosensor engineering; high-throughput screening; drug discovery; small molecules; nanomedicine; tnf receptor signaling; inflammation; neurodegeneration; alzheimer’s disease; multiple sclerosis
Interests: biomedical engineering; biomaterial design; polymeric nanoparticles; autophagy function; lysosomal acidification; metabolic disorders; non-alcoholic fatty liver disease; type II diabetes; neurodegenerative disease; Parkinson’s disease
Special Issue Information
Dear Colleagues,
Proteins are some of the most versatile and well-studied macromolecules that can be incorporated into cells and biomaterials for the engineering of biosensors with biomedical applications. Protein-based biosensors and biomaterials have gained special attentions as they offer new opportunities in the development of high-throughput screening platforms for drug discovery, laboratory and point-of-care diagnostics, and theranostic tools. Cell-based biosensors have been widely used in the selection of chemical compounds with new pharmaceutical formulations in protein targeting through high-throughput screening to generate lead drug candidates. Similarly, polymeric and lipid-based nanoparticles and nanovesicles have been developed as nanomedicine as well as biosensing tools for biomedical applications and the goal is to translate these therapies and tools into the clinics. We invite authors to submit original articles and review articles highlighting the latest advances in protein-based biosensors and biomaterials with high sensitivity and specificity as well as potential for miniaturization, mass production, and high-throughput applications.
Dr. Chih Hung Lo
Dr. Jialiu Zeng
Dr. Justin Kok Soon Tan
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cell-based biosensors
- biomaterial-based biosensors
- biomedical engineering
- high-throughput screening
- small molecules
- nanomedicine
- theranostic applications
- polymeric materials
- lipid-based materials
- self-assembly
